34,026 Car Accident Deaths Annually in America. 2 Times Worse Than Europe – 3 Time Worse Than Israel (safest)

34,026 Car Accident Deaths Annually in America. 2 Times Worse Than Europe - 3 Time Worse than Israel (safest)

34,026 Car Accident Deaths Annually in America. 2 Times Worse Than Europe – 3 Time Worse than Israel (safest)

Deaths from Road Traffic Injuries 2018 Don Karl Juravin World Health Organization stats

Deaths from Road Traffic Injuries 2018 Don Karl Juravin World Health Organization stats

Deaths From Road Traffic Injuries 2018 Don Karl Juravin World Health Organization

Deaths From Road Traffic Injuries 2018 Don Karl Juravin World Health Organization

80% of accidents are because of distractions

80% of accidents are because of distractions

JURAVIN RESEARCH

JURAVIN RESEARCH

DON JURAVIN RESEARCH finds that adhering to the European or Israeli safety and driving standards can save about 22,470 American lives a year.

22,470 American lives a year can be saved if we learn from Israel and also from the German, French and Italy”

— Don Juravin

ORLANDO, FLORIDA, UNITED STATES, February 22, 2019 /EINPresswire.com/ — 34,026 Car Accident Deaths Annually in America. 2 Times Worse Than Europe – 3 Time Worse than Israel (safest)

DON JURAVIN RESEARCH finds that adhering to the European or Israeli safety and driving standards can save about 22,470 American lives a year. 1.35 million die annually worldwide from car crashes while 20 to 50 million get injured.

+—————————————+
| Which Country is the Safest to Drive? |
+—————————————+

Comparing USA Vs. Europe top countries (Germany, France, Italy) Vs. Israel

+————+———–+——+——–+———-+———+——–+——-+
| World Best | Best Rate | USA | Israel | Euro-top | Germany | France | Italy |
+————+———–+——+——–+———-+———+——–+——-+
| Monaco | 0.00 |10.60 | 3.60 | 5.17 | 4.30 | 5.10 | 6.10 |
+————+———–+——+——–+———-+———+——–+——-+

WINNER-SAFEST in Traffic Accident Deaths: ISRAEL

* Israel's deaths from road traffic injuries is 1.61 times safer than the world average
* Israel's deaths from road traffic injuries is 2.94 times safer than the USA
* Israel's deaths from road traffic injuries is 1.44 times safer than Euro-top

+—————+———–+——————–+————–+————–+—————+
| World average | Winner | Times better | Times better | Times better | Times better |
| | | than world average | than USA | than Euro | than Israel |
+—————+———–+——————–+——–+—–+————–+—————+
| 5.81 | Israel | 1.61 | 2.94 | 1.44 | — |
+—————+———–+——————–+————–+————–+—————+

Don Karl Juravin compared the safety & health of the countries around the world in his upcoming book: Fix America to be #1

+———————————–+
| Deaths From Road Traffic Injuries |
+———————————–+

Comparing USA Vs. Europe top countries (Germany, France, Italy) Vs. Israel
relative per 100K population | lower is better | 2018 report

https://bit.ly/2ty9UhB

+———————————–+
| Annual Deaths in Absolute Numbers |
+———————————–+

* Israel: 302 annual deaths
* Euro-top: 10,857 annual deaths
* USA: 34,026 annual deaths

Assuming the population of USA 321 million, Israel 8.4 million, Euro-top 210 million (Germany 82 million, France 67 million, Italy 61 million)

+——————————————+
| World Traffic Accident Death Key Factors |
+——————————————+

* Worldwide car accidents deaths: An unspoken staggering estimated 1.35 million people die each year as a result of road traffic crashes.

* Worldwide Accident injuries: A huge toll on families and the economy are 20 to 50 million injuries from traffic accidents injured annually.

* Road traffic crashes are a major cause of death among all age groups and the leading cause of death for children and young adults aged 5–29 years.

* Income & car accidents: My research shows that the risk of dying in a road traffic crash is more than 3 times higher in low-income countries than in high-income countries. More than 90% of road traffic deaths occur in low-income and middle-income countries. Road traffic injury death rates are highest in the African region. Even within high-income countries, people from lower socioeconomic backgrounds are more likely to be involved in road traffic crashes.

* Young male Vs. female driving: Males are more likely to be involved in road traffic crashes than females. About three quarters (73%) of all road traffic deaths occur among young males under the age of 25 years who are almost 3 times as likely to be killed in a road traffic crash as young females.

* Speed: Every 1% increase in mean speed produces a 4% increase in the fatal crash risk and a 3% increase. An increase in average speed is directly related both to the likelihood of a crash occurring and to the severity of the consequences of the crash. For example, In the serious crash risk.

* Pedestrians: The death risk for pedestrians hit by car fronts rises rapidly (4.5 times from 50 km/h to 65 km/h).

* Car-to-car side impacts: The fatality risk for car occupants is 85% at 65 km/h.

* The 2030 Agenda for Sustainable Development has set an ambitious target of halving the global number of deaths and injuries from road traffic crashes by 2020.

* GDP cost of car accidents: Road traffic crashes cost most countries 3% of their gross domestic product.

* Vulnerable road users: More than 50% of all road traffic deaths are among vulnerable road users: pedestrians, cyclists, and motorcyclists.

* Mobile phone usage while driving: Drivers using mobile phones are 4 times more likely to be involved in a crash than drivers not using a mobile phone. Using a phone while driving slows reaction times (notably braking reaction time, but also a reaction to traffic signals), and makes it difficult to keep in the correct lane, and to keep the correct following distances.

* Hands-free phones are not much safer than hand-held phone sets, and texting considerably increases the risk of a crash.

* Seat-belt wearing reduces the risk of death among front-seat passengers by 40−65% and can reduce deaths among rear-seat car occupants by 25−75%.

* Only 57% of countries require seat-belts to be used in cars by both front-seat and rear-seat passengers (38% of low-income countries, 54% of middle-income countries and 83% of high-income countries).

* The use of child restraints (which include infant seats, child seats and booster seats) can reduce deaths of infants by as much as 70% and deaths of small children by between 54% and 80% in the event of a crash.

Credits:
DOI: 10.5281/zenodo.2551844, 10.5281/zenodo.2567780
Source: World Health Organization 2018 (based on 2013 stats)

Research by:
Don Karl Juravin
https://juravin.com/

Twitter: https://twitter.com/DonJuravin
Facebook: https://www.facebook.com/Juravin
LinkedIn: https://www.linkedin.com/in/juravin/
Pinterest: https://www.pinterest.com/Juravin
YouTube: https://www.youtube.com/DonJuravin
Instagram: https://www.instagram.com/juravin/
Tumblr: https://juravin.tumblr.com/
Reddit: https://www.reddit.com/user/Juravin
Blog: https://comparison-health-safety.blogspot.com/
Google scholar: http://scholar.google.com/citations?user=jCdHy0EAAAAJ&hl=en
Researchgate: https://researchgate.net/profile/Don_Juravin
Quora: https://www.quora.com/profile/Don-Karl-Juravin
Medium: https://medium.com/@Juravin
Wordpress: https://juravin.wordpress.com/
Google+ https://plus.google.com/u/0/+DonJuravin
Ted Talk: https://www.ted.com/profiles/7929318
Scribd: https://www.scribd.com/user/377772125/Don-Karl-Juravin

Don Karl Juravin
Don Karl Juravin
+1 773-800-0055
email us here
Visit us on social media:
Facebook
Twitter
Google+
LinkedIn


Source: EIN Presswire

NASA Brings Out The Lost Reports Of Hector R. Rojas, As Reported By Dr. Roja's Biographer

The reports contain the calculations to land on the Moon that guaranteed the safety of the astronauts of the Apollo 11 mission.

WASHINGTON, D.C., UNITED STATES, February 22, 2019 /EINPresswire.com/ — The reports contain the calculations to land on the Moon that guaranteed the safety of the astronauts of the Apollo 11 mission and the success of the first manned lunar landing on Sunday, July 20, 1969.

The National Aeronautics and Space Administration (NASA) has published recently inside the Server of its Scientific and Technical Information Program, the first three studies conducted by the Venezuelan astrophysicist Hector R. Rojas, between August 1966 and February 1967, as part of his job in the Apollo Lunar Program. These scientific studies contain the calculations for the landing of the Apollo 11 mission on the surface of the Moon. This year will be the 50th commemoration of this historical milestone, which was the arrival of the human being to the Moon on July 20, 1969.

The biographer of Dr. Hector R. Rojas, astrophysicist for the University of Paris, has been the manager of spreading the news. The Spanish-Venezuelan professor and writer Pierre Monteagudo explained that he had previously received a communication from the technical and scientific management office of NASA, indicating that once the documentation issued by the Johnson Space Center, of Houston, Texas, was obtained, they proceeded they proceeded to publish the three studies written by Dr. Rojas in the Technical Report Server, which are available to the public from Wednesday, February 20, 2019. The NASA Technical Reports Server (NTRS) contains all the scientific studies created or sponsored by NASA since 1958, but interestingly, the reports prepared by Hector R. Rojas were missing. They have had to spend more than 50 years so that finally, the full text of the three documents is now available in pdf format that can be viewed and downloaded by any interested person.

The first report published on December 1st, 1966, is the mathematical technique created by the astrophysicist Hector R. Rojas and contains a series of spatial coefficients that helped him collect data from the surface of the Moon that he later used to calculate, with mathematical precision, the optimal lunar area for the landing of manned ships. Through the successive transformations of his own method, Dr. Rojas was able to determine the temperature that the astronauts would find in the equatorial region of the Moon, when they disembarked on its surface. The scientist used extrapolation to obtain a temperature distribution, known in NASA as “Contours of Rojas” which is expressed in the second report, published on February 1th, 1967. In this way, he was able to demonstrate that the surface temperature of the satellite was related to the lunar topography, since there were different readings in craters, hillsides and plains. This is how Dr. Rojas prepared a map of the topography and relief of the Moon much more accurately than that obtained only with images. In the third report, published in July 1967, the astrophysicist presented a detailed analysis of the composition of the Moon and the amount of sunlight reflected by the lunar surface, based on observations made from Earth and the analysis of the images taken by the automated space probes of the Surveyor and Lunar Orbiter series, which orbited the Moon, before sending the manned missions. The three NASA studies were originally published by the Manned Spacecraft Center (MSC) in Houston, Texas.

The set of investigations that were carried out allowed Hector R. Rojas to study in detail the areas of the lunar surface, with less roughness, where the Apollo missions finally landed.

Other studies of this author to NASA that are pending publication in the Server of Technical and Scientific Reports are:

•Report 4, published in 1968, with the title: Third Application of the Successive Transformation Method. For the analysis of the Surveyor and Lunar Orbiter photographs, written by Hector R. Rojas, Ph. D., for NASA – Manned Spacecraft Center (MSC). Due to its enormous importance, this study was translated into French and sent to scientists and institutions in France by the United States Senate Committee on Aeronautical and Space Sciences.

•Study of the Radiation of Microwaves in the Atmosphere of Venus, published by NASA, in 1968, from the work done by Dr. Rojas, at the Institute of Technological Research of Illinois, in Chicago.

All the work done for years by Pierre Monteagudo, to achieve the recognition of Hector R. Rojas as the author of NASA reports, is part of a process of global claim of the genius and figure of the astrophysicist and constitutes a tribute to his posthumous memory, which consolidates with the recovery of its scientific legacy, through the publications made by NASA. All the available information about this scientist can be read in the book, "The Rojas File".

Pierre Monteagudo
Scientific Writer
674 59 68 94
email us here


Source: EIN Presswire

AV-Comparatives’ Awards Ceremony and Summary Report for 2018

(c) Photo Wedermann

AV-Comparatives Award Ceremony at Swarovski Crystal Worlds

AV-Comparatives Boblseigh Championship

AV-Comparatives Boblseigh Championship

AV-Comparatives Awards 2018

AV-Comparatives Awards 2018

Best-performing IT security software recognised at Swarovski Crystal Worlds

INNSBRUCK / WATTENS, TYROL, AUSTRIA, February 22, 2019 /EINPresswire.com/ — AV-Comparatives’ Awards Ceremony for 2018

Click here for details and photos of the Award Ceremony

Click here for details of the Summary Report

Best-performing IT security software recognised at Swarovski Crystal Worlds

As cybercrime becomes ever more common and ever more sophisticated, the importance of effective security programs increases accordingly. AV-Comparatives’ Awards Ceremony for its 2018 tests recognised those vendors whose products provide truly effective protection against IT threats. The event was held on 4th and 5th of February 2019 in Innsbruck, and 36 IT-security specialists from 12 countries attended. In addition to the awards ceremony itself, the event included a security conference, with speakers on cybersecurity-related topics. As cyber-threats continue to evolve, so must the testing of security solutions, and so AV-Comparatives’ new Enhanced Real-World Test, which will be run for the first time in 2019, was introduced.

Participants were also treated to a thrilling bobsleigh ride at the Olympic Bobsleigh and Luge Track in Igls. The bobs reached a top speed of over 120 km/h!

Awards

At the Awards Ceremony, various awards were handed over for top-performing security products tested during the course of 2018. There were AV-Comparatives Approved Product Awards for qualifying consumer and business products. In addition, there were various awards for the Consumer Main Test Series – both for individual tests, and for overall results across the test series.

Product of the Year Award

Avast received the Product of the Year Award 2018 (1st place overall), having reached top scores in every test throughout the year. The award is given for the highest overall results across all the tests in the series.
Bitdefender was rewarded with the Outstanding Product Award 2018, having also reached top scores in all the tests. This award is given when two products achieve identical overall scores in the Consumer Main Test Series; the product which has already won Product of the Year, or won it more recently, receives the Outstanding Product Award.
AVG, Avira, Kaspersky Lab and Tencent achieved excellent results across the different test categories, and all received

Top-Rated Product Awards.

Security awards for protection, performance, malware removal and low false alarms
Gold, Silver and Bronze awards were given for each of the following AV-Comparatives’ Tests: Real-World Protection, Malware Protection, Low False-Positives, Low System-Impact and Malware Removal. For details, please see “Overview of levels reached during 2018” in our 2018 Summary Report. Vendors receiving awards for individual tests were Avast, AVG, Avira, Bitdefender, Emsisoft, ESET, K7, Kaspersky Lab, and Tencent.

Security conference

Franz Unterluggauer opened the day with a presentation on how the Innovation Agency of Tirol stimulates business transformation through digitalization. Next, Dr. Peter J. Mirski, Professor of Management and IT at the Management Center Innsbruck (MCI) gave his view on how to improve ‘IT and security education of tomorrow’. After the break, the improvements of the AV-Comparatives’ Enhanced Real-World-Test methodology were presented.

Message from the CEO

AV-Comparatives’ founder and CEO Andreas Clementi commented, “We would like to thank everyone who came to this event in Innsbruck for making it such a success. As cybercrime continues to rise, effective security products are more important than ever. We congratulate the security vendors whose products stood up to rigorous independent testing that mimics real-world scenarios.”

AV-Comparatives’ Tests

The increasing number and variety of threats means that rigorous testing is required to determine which security products are really effective at protecting a system, whilst allowing the user to work normally without interruptions. AV-Comparatives’ Consumer Main Test Series subjects consumer security programs to not one but four main tests throughout the course of each year. The Real-World Protection Test checks a product’s ability to protect against real-world Internet threats; the Malware Protection Test requires each product to identify thousands of recent malicious programs; the Performance Test verifies whether the security programs can provide protection without slowing down the PC; and the Malware Removal Test checks how well each product can remove malware that has already infected a PC. Additionally, there is a False Positives Test ensures that false alarms are kept to a minimum. This variety of tests ensures that security products are not just strong in one or two areas, but provide all-round protection and performance.

About AV-Comparatives

AV-Comparatives is an independent organization offering systematic testing that checks whether security software, such as PC/Mac-based antivirus products and mobile security solutions, lives up to its promises. Using one of the largest sample collections worldwide, it creates a real-world environment for truly accurate testing. AV-Comparatives offers freely accessible results to individuals, news organizations and scientific institutions. Certification by AV-Comparatives provides an official seal of approval for software performance which is globally recognized.
AV-Comparatives works closely with several academic institutions, especially the University of Innsbruck’s Department of Computer Science, to provide scientific testing methods. www.av-comparatives.org

The results can be used by editors / media / bloggers etc. for free. Please give as source https://www.av-comparatives.org

Mediacontact
AV-Comparatives
+43 720 115542
email us here


Source: EIN Presswire

Gifford-Mcmahon Cryocoolers Market by Manufacturers,Types,Regions and Applications Research Report Forecast to 2023

PUNE, INDIA, February 22, 2019 /EINPresswire.com/ —
WiseGuyReports.Com Publish a New Market Research Report On –“ Gifford-Mcmahon Cryocoolers Market by Manufacturers,Types,Regions and Applications Research Report Forecast to 2023”.

Gifford-Mcmahon Cryocoolers Industry 2019

Description:-

The Gifford-Mcmahon Cryocoolers industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Gifford-Mcmahon Cryocoolers market size to maintain the average annual growth rate of 5.08% from 131 million $ in 2015 to 152 million $ in 2018, The analysts believe that in the next few years, Gifford-Mcmahon Cryocoolers market size will be further expanded, we expect that by 2023 , The market size of the Gifford-Mcmahon Cryocoolers will reach 194 million $.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/3742397-global-gifford-mcmahon-cryocoolers-market-report-2019

For more information or any query mail at sales@wiseguyreports.com

This Report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size.

Besides, the report also covers segment data, including: type segment, industry segment etc. cover different segment market size. Also cover different industries clients’ information, which is very important for the Major Players.

Sections:-

Section 1: Free——Definition

Section (2 3): 1200 USD——Manufacturer Detail (Sumitomo, Cryomech, Brooks Automation, Advanced Research System, Vacree Technologies)

Section 4: 900 USD——Region Segmentation (United States, Canada, South America, China, Japan, India, Korea, Germany, UK, France, Italy, Europe, Middle East, Africa, GCC)

Section (5 6 7): 500 USD——Product Type (≤10K, 10K-30K, >30K, , ), Industry(Military, Biology & Medical Use, Research & Development, Aerospace, ) and Channel (Direct Sales, Distributor) Segmentation

Section 8: 400 USD——Trend (2019-2023)

……..

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/3742397-global-gifford-mcmahon-cryocoolers-market-report-2019

Table Of Contents – Major Key Points

Section 1 Gifford-Mcmahon Cryocoolers Product Definition

Section 2 Global Gifford-Mcmahon Cryocoolers Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Gifford-Mcmahon Cryocoolers Shipments
2.2 Global Manufacturer Gifford-Mcmahon Cryocoolers Business Revenue
2.3 Global Gifford-Mcmahon Cryocoolers Market Overview

Section 3 Manufacturer Gifford-Mcmahon Cryocoolers Business Introduction
3.1 Sumitomo Gifford-Mcmahon Cryocoolers Business Introduction
3.1.1 Sumitomo Gifford-Mcmahon Cryocoolers Shipments, Price, Revenue and Gross profit 2015-2018
3.1.2 Sumitomo Gifford-Mcmahon Cryocoolers Business Distribution by Region
3.1.3 Sumitomo Interview Record
3.1.4 Sumitomo Gifford-Mcmahon Cryocoolers Business Profile
3.1.5 Sumitomo Gifford-Mcmahon Cryocoolers Product Specification
3.2 Cryomech Gifford-Mcmahon Cryocoolers Business Introduction
3.2.1 Cryomech Gifford-Mcmahon Cryocoolers Shipments, Price, Revenue and Gross profit 2015-2018
3.2.2 Cryomech Gifford-Mcmahon Cryocoolers Business Distribution by Region
3.2.3 Interview Record
3.2.4 Cryomech Gifford-Mcmahon Cryocoolers Business Overview
3.2.5 Cryomech Gifford-Mcmahon Cryocoolers Product Specification
3.3 Brooks Automation Gifford-Mcmahon Cryocoolers Business Introduction
3.3.1 Brooks Automation Gifford-Mcmahon Cryocoolers Shipments, Price, Revenue and Gross profit 2015-2018
3.3.2 Brooks Automation Gifford-Mcmahon Cryocoolers Business Distribution by Region
3.3.3 Interview Record
3.3.4 Brooks Automation Gifford-Mcmahon Cryocoolers Business Overview
3.3.5 Brooks Automation Gifford-Mcmahon Cryocoolers Product Specification
3.4 Advanced Research System Gifford-Mcmahon Cryocoolers Business Introduction

Section 4 Global Gifford-Mcmahon Cryocoolers Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.1.2 Canada Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.2 South America Country
4.2.1 South America Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.3 Asia Country
4.3.1 China Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.3.2 Japan Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.3.3 India Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.3.4 Korea Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.4 Europe Country
4.4.1 Germany Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.4.2 UK Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.4.3 France Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.4.4 Italy Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.4.5 Europe Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.5 Other Country and Region
4.5.1 Middle East Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.5.2 Africa Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.5.3 GCC Gifford-Mcmahon Cryocoolers Market Size and Price Analysis 2015-2018
4.6 Three Global Gifford-Mcmahon Cryocoolers Market Segmentation (Region Level) Analysis 2015-2018
4.7 Global Gifford-Mcmahon Cryocoolers Market Segmentation (Region Level) Analysis

Section 5 Global Gifford-Mcmahon Cryocoolers Market Segmentation (Product Type Level)
5.1 Global Gifford-Mcmahon Cryocoolers Market Segmentation (Product Type Level) Market Size 2015-2018
5.2 Different Gifford-Mcmahon Cryocoolers Product Type Price 2015-2018
5.3 Global Gifford-Mcmahon Cryocoolers Market Segmentation (Product Type Level) Analysis

Section 6 Global Gifford-Mcmahon Cryocoolers Market Segmentation (Industry Level)
6.1 Global Gifford-Mcmahon Cryocoolers Market Segmentation (Industry Level) Market Size 2015-2018
6.2 Different Industry Price 2015-2018
6.3 Global Gifford-Mcmahon Cryocoolers Market Segmentation (Industry Level) Analysis

Section 7 Global Gifford-Mcmahon Cryocoolers Market Segmentation (Channel Level)
7.1 Global Gifford-Mcmahon Cryocoolers Market Segmentation (Channel Level) Sales Volume and Share 2015-2018
7.2 Global Gifford-Mcmahon Cryocoolers Global Gifford-Mcmahon Cryocoolers Market Segmentation (Channel Level) Analysis

Continued……

Buy 1-user PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3742397

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Which Antivirus Software is used in the Real-World? A research by AV-Comparatives – Annual Security Survey – 2019

Logo AV-Comparatives

Logo AV-Comparatives

AV-Comparatives Survey

AV-Comparatives Survey

Which type of Security Solution do you use?

Which type of Security Solution do you use?

The survey of computer users gives an insight into computer security, and which institutes they trust to provide reliable information on security issues.

A majority of users were well protected, having not suffered a infection. A third stated that their security product had blocked malware, indicating how easy it is to encounter a threat.”

— Andreas Clementi, ceo

INNSBRUCK, TYROL, AUSTRIA, February 22, 2019 /EINPresswire.com/ — The AV-Comparatives annual survey of computer users worldwide gives us an insight into their understanding of computer security issues, requirements in security software, and which institutes they trust to provide reliable information on security issues.

The detailed results can be found on our website and as PDF

Every year AV-Comparatives conducts a security survey asking users their opinion and preference on security products. In our global survey we ask users on various security related topics. The opinions and preferences from the end user community provide us with valuable feedback. The results help us increase the relevance and value of anti-virus software testing. We want to thank all who join the surveys and spend their time to complete them.

Reliable end user feedback from all continents

In our annual security survey we received responses from 88 countries coming from all continents around the globe. The survey was conducted from December 14th, 2018 to December 24th, 2018.

Some highlights are:

AV-Comparatives determined, that majority of users (86%) were well protected in the last 6 months, having not suffered a malware infection in this period. A little over a third (35%) stated that their security product had blocked malware within the last week, indicating how easy it is to encounter a threat. So AV-Tests are very important, to inform about the quality of the products.

The number of users who rely on free desktop security software has risen again this year, standing at 44% of users. There has been a drop in the number of users without antivirus software, which is now down to 0.5%.
Over three quarters of this year’s respondents have moved to Windows 10, leaving Windows 7 with under a fifth of users.
A little under a half of respondents (45%) use a Virtual Private Network (VPN). In Iran, UAE, Iraq and China, at least three quarters of users deploy a VPN.

Google Chrome is the most popular browser, with getting on for half of respondents (45.6%) using it. Mozilla Firefox accounts for a lot of the remaining users, with a share approaching a third (29.2%). Despite being built into the increasingly popular Windows 10, and being Microsoft’s recommended browser on this OS, Microsoft Edge is only used by one in 20 of users overall.

Click here to read the full AV-Comparatives Security Survey

About AV-Comparatives

AV-Comparatives is an independent organization offering systematic testing that checks whether security software, such as PC/Mac-based antivirus products and mobile security solutions, lives up to its promises. Using one of the largest sample collections worldwide, it creates a real-world environment for truly accurate testing. AV-Comparatives offers freely accessible results to individuals, news organizations and scientific institutions. Certification by AV-Comparatives provides an official seal of approval for software performance which is globally recognized.

AV-Comparatives works closely with several academic institutions, especially the University of Innsbruck’s Department of Computer Science, to provide scientific testing methods. www.av-comparatives.org

Mediacontact
AV-Comparatives
+43 720 115542
email us here


Source: EIN Presswire

Global Digital Pathology Market Segmentation, Application, Technology & Market Analysis Research Report 2023

New Study on “2018-2023 Digital Pathology Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

PUNE , MAHARASHTRA, INDIA, February 22, 2019 /EINPresswire.com/ — Global Digital Pathology Industry

New Study on “2018-2023 Digital Pathology Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Digital Pathology market is expected to grow at CAGR of 15% from 2018 to 2023. Diagnostic devices are the largest segment of Digital Pathology market and expected to be the largest segment in the year 2021 however, Analytics is the fastest growing segment of Digital pathology market. Resource Integration and Remote diagnostics are major motivators of the market. In recent trends, more and more pathologies are adopting digital pathology system. The market is growing significantly owing to quick processing and result accuracy of digital pathology, increased demand from point of care devices, workflow efficiency in laboratory management system and so on. though, higher initial cost of installation, lack of infrastructure in developing countries

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3204451-global-digital-pathology-market-research-and-forecast-2018-2023

Geographically, global digital pathology market is segmented into North America, Europe, Asia Pacific and Rest of the world. North America is having major market share owing to continual deployment of R&D investment, rising adoption of digital imaging, supportive government policies and regulations and so on. US is the major country in this region in the forecasted year. Asia Pacific is growing at a significant pace owing to the growing investments in the medical field, rising penetration of the digital imaging in emerging economies, and the presence of untapped opportunities. APAC healthcare industry has highly influenced the digital pathology owing to rising incidence of cancer. Apart from that, increasing demand for novel treatment options, better patient care facilities, and reduction in laboratory expenses are further anticipated to drive demand in the forecasted year.

Key companies profiled in the report are 3dhistech LTD., Apollo Pacs INC., Aurora Interactive LTD., Barco, Definiens AG, Digipath INC., Huron Technologies International INC., Indica Labs INC., Leica Microsystems GmbH, Ligolab LLC, Microdimensions, Mikroscan Technologies INC., Nikon Instruments INC., Pathxl, Pixcelldata LTD., Proscia INC., Sectra, Sunquest Information Systems, Sysmex Corporation, Ventana Medical Systems INC., Viewsiq, Visiopharm, Xifin INC.

RESEARCH METHODOLOGY

The market study of digital pathology market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:

Financial reports of companies involved in the market
Authentic Public Databases
Whitepapers, research-papers and news blogs
Company websites and their product catalogue.
Supplier Websites such as Alibaba, amazon for pricing analysis.
The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.

Market Segmentation:

Global digital pathology market is segmented on the basis of product and services, end user, application and regional outlook.

Global Digital Pathology Market Research and Analysis, By Product and Services
Global Digital Pathology Market Research and Analysis, By End User
Global Digital Pathology Market Research and Analysis, By Application
Global Digital Pathology Market Research and Analysis, By Region
THE REPORT COVERS:
Comprehensive research methodology of Global digital pathology market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global digital pathology market.
Insights about market determinants which are stimulating the Global digital pathology market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Some points from table of content:

CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY PRODUCT
1.2.2. BY APPLICATION
1.2.3. BY END USER
1.2.4. BY GEOGRAPHY
1.2.5. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.3. CHINA
2.3.4. INDIA
2.3.5. REST OF THE WORLD

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3204451-global-digital-pathology-market-research-and-forecast-2018-2023

CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RESOURCE INTEGRATION IS A MAJOR DRIVER IN DIGITAL PATHOLOGY MARKET
3.1.2. QUICK PROCESSING AND RESULT ACCURACY
3.1.3. NEW AND INNOVATIVE TECHNOLOGIES ARE DRIVING THE MARKET
3.1.4. INCREASED DEMAND FROM POINT OF CARE DEVICES
3.1.5. MORE CONVENIENT FOR THE DIAGNOSTIC CENTRES AS WELL AS PATIENTS
3.1.6. WORKFLOW EFFICIENCY IN LABORATORY MANAGEMENT SYSTEM
3.1.7. REMOTE AREA CAN BE COVERED THROUGH TELEPATHOLOGY SYSTEM
3.2. RESTRAINTS
3.2.1. HIGHER INITIAL INSTALLATION COST
3.2.2. LACK OF INFRASTRUCTURE IN DEVELOPING COUNTRIES TO IMPLEMENT DIGITAL PATHOLOGY SYSTEM
3.3. OPPORTUNITIES
3.3.1. EMERGING MARKET SUCH AS INDIA AND CHINA ARE MOST OPPORTUNITY MARKETS
3.3.2. NO ENTRY BARRIER FOR NEW ENTRANTS
CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCTS AND SERVICES
4.1.1. DIAGNOSTIC DEVICES
4.1.2. SCANNERS AND MICROSCOPE
4.1.3. COMMUNICATION PLATFORM
4.1.4. STORAGE
4.1.5. OTHERS
4.2. GLOBAL DIGITAL PATHOLOGY MARKET, BY END USER
4.2.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
4.2.2. DIAGNOSTIC CENTRES
4.2.3. ACADEMICS CENTRES
4.3. GLOBAL DIGITAL PATHOLOGY MARKET, BY APPLICATION
4.3.1. ANATOMICAL PATHOLOGY
4.3.2. CHEMICAL PATHOLOGY
4.3.3. FORENSIC PATHOLOGY
4.3.4. CLINICAL PATHOLOGY
4.3.5. IMMUNOPATHOLOGY PATHOLOGY

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
841-198-5042
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

USPTO Grants Divisional Patent to Integral BioSystems for its NanoM™ Drug Delivery Platform

The USPTO has issued a Divisional Patent for Integral BioSystems’ NanoM™, the firm’s flagship sustained release drug formulation platform

With this Divisional Patent grant, NanoM™ is an even more powerful development tool”

— Dr. Shikha Barman

BEDFORD, MA, US, February 21, 2019 /EINPresswire.com/ — Boston-area drug development firm Integral BioSystems has received a Divisional Patent grant from the USPTO on one of its flagship inventions, NanoM™(“Methods and Biocompatible Compositions to Achieve Sustained Drug Release in the Eye”, United States Patent #9931306 issued on April 3, 2018).

Developed as a drug delivery platform for the formulation of new chemical entities as well as already-approved drugs in a 505(b)2 environment, NanoM™ technology is a novel, patented, differentiated and improved delivery approach for administering sustained-release medications, both small molecules and biologics to ocular and other tissue types, both as therapies adjunct to surgical interventions as well as stand-alone sustained release drug therapies in ophthalmology, urology and other accessible tissue spaces. The NanoM technology is applied as a biodegradable, nanostructured wafer that has key characteristics unique to its drug release and tissue biocompatibility. This is particularly useful for the development of improved, next-generation therapies in ophthalmic indications in glaucoma, cataract surgery, etc. as well as the development of regimens to treat cancer and infections for other tissues and organs. This innovation can be considered transformational and can be the platform engine for many future sustained release products.

About Integral BioSystems
Since its formation in 2011, Integral BioSystems has established credibility in drug formulation, CMC consulting, analytical method development and methods qualification, as well as scale-up process engineering. Along with its strong presence as an ophthalmic product development CRO, the company also has expertise in other routes, including injectables, infusions, topical dermal gels/creams, and nanocrystals. Integral BioSystems provides expertise and know-how in developing both front-of-the-eye and back-of-the-eye products, offering complete development services in pre-formulation, including bioanalytical.

For companies seeking to develop a new product that is using a re-purposed drug, Integral offers its innovative delivery systems as licensable technologies to build value into prospective clients’ drug products through a 505b2 regulatory strategy. With multiple billion dollar drug products going off-patent, this presents a cost effective way to develop an extended product life cycle with novel IP. In this manner, Integral will offer its insight and technological innovations in drug delivery to strategize and improve the customer’s product portfolio. To this effect, Integral BioSystems has been a development partner for both innovative and generic companies.

Dave Karasic
Integral BioSystems
+1 617-820-8483
email us here


Source: EIN Presswire

River Therapies is First in Greater Pittsburgh Area to Use Innovative I-PAS™ for Concussion and Vestibular Patients

River Therapies has added the FDA-cleared I-PAS™ to their practice as part of their River Concussion Group. I-PAS provides a range of OVRT tests and exercises.

PITTSBURGH, PA, US, February 21, 2019 /EINPresswire.com/ — River Therapies proudly announces they are the first physical therapy clinic in the Pittsburgh area to add an I-Portal ® Portable Assessment System (I-PAS™) to their practice. The I-PAS, developed by Neuro Kinetics, Inc. (NKI), is a game-changing, neural functional assessment tool. It is portable, FDA-cleared, and looks much like a virtual reality system. River Therapies can now offer an extensive battery of Oculomotor (eye movement), Vestibular (balance) and Reaction Time (or OVRT) tests and exercises to help the professionals at River Therapies address a multitude of injuries such as concussions.

Over the last 19 years, River Therapies has grown to now offer a variety of services including physical therapy, occupational therapy, psychology, and social work. Founder and Director Cherie River became a speech therapist after her nephew was diagnosed with Down’s Syndrome. Her passion to help those as challenged as her nephew now encompasses: River Therapies, River Pediatric Therapies, River School Therapies, and River Concussion Institute. These practices treat adults, adolescents, and children in schools, homes, and clinics across the Greater Pittsburgh region.

The clinic will use I-PAS as part of its newly formed River Concussion Group, to address the needs of adult to school-aged children who suffer from mild traumatic brain injury (mTBI). River explained that their goal is to bridge the gap between clinic, schools, and work by creating a process that addresses all aspects of concussion treatment and rehabilitation. River Concussion Institute is unique in the sense that they incorporate speech therapy, occupational therapy, physical therapy, psychology, and counseling into the concussion treatment program as needed per patient. River does not consider the concussion as an isolated event, but rather looks at entire function of the person so that they can start enjoying life again!

“Our experience has taught us how to assess and clinically integrate new technologies. Being the first to integrate I-PAS into our clinical practice provides our patients with the most clinically advanced, neuro-functional assessment tool, allowing River Concussion to design and implement the most appropriate and beneficial treatment possible for our clientele ” said River. “We are going to use it for baselines, for rehabilitation, and for post-treatment and post-season assessments.” She went on to explain that, having observed I-PAS first hand, nothing else provides the insight and neuro-functional measurements that Rivers Concussion and its clientele will be able to get with I-PAS. This puts Rivers’ practitioners in a unique position to design and implement the most powerful treatment plans.

Dr. John Schneider, a Physical Therapist at River Therapies, echoed River’s excitement about the inclusion of I-PAS in their treatment plan. "I couldn't be more excited to use the I-PAS system,” Dr. Schneider said. “It is especially valuable to me as I now have a way to determine if the interventions I choose for my patients are effective, or if I need to try a different approach. Our top priority is getting our patients better and back to doing what they love, and now we have a tool to let us know when and how we are achieving that goal." The objectivity of the data the device provides was also cited as a key benefit in comparison to alternative assessment tools, which are complementary and will be used when indicated to provide additional insight into a patient’s health condition.

NKI has supplied comprehensive neuro-functional diagnostic and assessment tools to professionals around the globe for more than three decades. The U.S. Food and Drug Administration (FDA) cleared fourteen oculomotor, vestibular, and reaction time tests on NKI’s I-PAS in November 2017. Since then, a series of exciting developments have taken place including Indy Racing League’s, LLC (INDYCAR), announcement to include I-PAS as part of their concussion evaluation protocol. Also, in June 2018 it was announced that NKI’s I-Portal™ technology, including I-PAS, was used to test and confirm inner-ear damage suffered by U.S. Diplomats to Cuba.

ABOUT NKI

Neuro Kinetics, Inc. (NKI) is the leader in clinical eye tracking and non-invasive neuro-functional diagnostics and monitoring. Abnormal eye responses have been connected to more than 200 diseases and medical conditions. With 24 issued patents and over 150 installations, NKI’s FDA-cleared I-Portal® devices are sold to physical therapists, audiologists, ENT’s, neurotologists, neuro-chiropractors, neuro-ophthalmologists and neurologists around the globe. The company's cleared diagnostic platforms include the I-PAS® (I-Portal® Portable Assessment System), I-Portal® NOTC (Neuro-Otologic Test Center), I-Portal® VNG, (Video Nystagmography) and I-Portal® VOG (Video Oculography), along with related accessories, software, training and support services.

Concussions, as mTBI’s are widely known, are an increasing public health concern. The need for an objective diagnostic device has made health care practitioners eager for a system that can measure concussion symptoms acutely and over time with speed, precision and reliability. Recent third-party research initially indicates a battery of OVRT (oculomotor, vestibular, and reaction time) tests, in combination with NKI’s I-Portal devices, can support a more accurate diagnosis of mTBI (concussion) symptom measurement both acutely and during convalescence. Please refer to NKI’s website and the resources page for papers reporting on I-Portal’s role in various concussion studies. NKI is actively working toward gaining clearance for its I-Portal® systems as an aid in the diagnosis of concussion based on this and other research. To learn more about NKI, please visit www.neuro-kinetics.com.

ABOUT RIVER THERAPIES

River Therapies is a dynamic private practice serving the Greater Pittsburgh Area of Pennsylvania comprised of River Therapies, River Pediatric Therapies, River School Therapies, and River Concussion Institute. They are staffed with a combination of over 50 outstanding, certified, and licensed Speech Language Pathologists, Developmental Therapists, Behavioral Therapists, Occupational Therapists, Physical Therapists, Psychologists, and Social Workers who treat adults, adolescents, and children. Services are provided in schools, homes, or within the Fox Chapel and Cranberry Clinics. Together they provide a comprehensive approach to intervention that focuses on the whole person because “Each step counts!”

From warm-water pool therapy to their especially designed and unique equipment, River has clients covered for an efficient and effective treatment plan. Pediatric, school-age services, in particular, are designed to heighten the sense of joy and accomplishment and to optimize the benefits of the natural environment. This is achieved by consulting in the child's school, home, preschool, or day care, and by helping their teachers, caregivers and family members to become a part of the process in reaching the child's goals. Combining nearly 20 years of experience with friendly and caring service, River Therapies focuses on your therapy needs in a positive and fun atmosphere! To learn more about River Therapies, please visit Riverpediatric.com.

Cherie River
River Therapies
+1 412-767-5967
email us here


Source: EIN Presswire

Helping Bile Duct Cancer Patients Find Specialists Nationwide

The Cholangiocarcinoma Foundation and Komodo Health Offer a First of Its Kind Interactive Map Connecting Patients and Doctors

SALT LAKE CITY, UT, USA, February 21, 2019 /EINPresswire.com/ — The Cholangiocarcinoma Foundation (CCF) has partnered with Komodo Health to create an interactive map for patients to find healthcare providers experienced in cholangiocarcinoma, nationwide. Patients may access CCF’s Specialist Finder here.

Cholangiocarcinoma, a cancer of the bile ducts, is often labeled a silent disease because many times the signs and symptoms go unnoticed until the cancer is in the advanced stage. Even when early signs and symptoms become known, they may be vague and easily attributed to another disease. Approximately 9,000 new cases are diagnosed each year—and these numbers are growing as cholangiocarcinoma has the second highest rising incidence rate amongst all cancers.

“Our patients struggle to find healthcare providers that provide the best standards of care for cholangiocarcinoma,” Stacie Lindsey, CCF Founder and President said. “Komodo Health’s healthcare map creates access for CCA patients to healthcare providers that are experienced with cholangiocarcinoma” Stacie continued.

Komodo Health and the Cholangiocarcinoma Foundation began their partnership in May of 2018. The agreement allows the Cholangiocarcinoma Foundation to access disease-specific insights to help get cholangiocarcinoma patients the right care at the right time.

“Specialist Finder will connect patients with the best standards of care and reduce the burden of this deadly disease.” Said Dr. Aswin Chandrakantan, Head of Product and Chief Medical Officer of Komodo Health.

Jordan Giles
Cholangiocarcinoma Foundation
+1 888-396-6731
email us here


Source: EIN Presswire

SMi’s Pharma Microbiology West Coast 2019 chair and speakers announced

Micro WC brochure cover

Pharmaceutical Microbiology West Coast is back after a successful event in 2018. This year the confex is at Hyatt Regency Mission Bay, USA on June 5-6, 2019.

SAN DIEGO, CALIFORNIA, UNITED STATES , February 21, 2019 /EINPresswire.com/ — SMi's 3rd Annual Pharmaceutical Microbiology West Coast conference and exhibition is sponsored by: Associates of Cape Cod, bioMérieux, Bioscience International, Charles River, DuPont, FujiFilm and Microbiologics

I am pleased to announce the Chair for the conference Ms. Ziva Abraham, CEO at Microrite, who will be joining us again due to the positive feedback received from past attendees.

Ziva has 25+ years of academic, research, clinical and industrial experience in microbiology and quality assurance. She received her master’s degree in microbiology with a focus on mycology and has conducted research on developing microbial Insecticides using entomogenous bacteria and fungi for her PhD degree. At present she is the CEO and Founder of Microrite, Inc., a California based consulting firm providing consulting and training services to pharmaceuticals, biotechnology, medical devices and in vitro diagnostics in the areas of quality assurance, quality control, microbiology, and validation.

As well as chairing the 2-day conference, Ziva will also be leading one of the two pre-conference workshops on 'Assessing a Holistic Approach to Microbial Contamination Control' details below.

EXPERT MICROBIOLOGY SPEAKERS INCLUDE:

IRVING FORD, Head of CAR T QC Laboratories, Celgene Corporation
Irving has over 28 years of QA/QC experience in pharmaceutical/biotechnology and cell/gene therapies industries.
Currently, Irving is working on a task force for creating an ISO Standard for apheresis collection. Irving is also co-authoring a White Paper for appropriate microbiological controls for ATMPs manufacturing.
Irving will be presenting a keynote session on 'Just in time release of CAR-T Cell therapies' on day one.

FRIEDRICH VON WINTZINGERODE, Senior Manager gASAT Microbiology, Global QC, Roche Diagnostics Gmbh
He is Head of Roche-Genentech global Endotoxin Expert Group and Roche-Genentech global SME on microbial impurity contaminations and LER. He joined Roche in 2001 working as Micro lab Manager and Senior Manager on various topics (environmental monitoring, biochemical cleaning analytics, microbiological IPC and analytics for release, endotoxin testing, LER).
Friedrich will be presenting a spotlight session on ‘Low Endotoxin Recovery (LER) on day one.

ANITA BAWA, Quality Control Director, Bayer Healthcare
Anita has 20 years of experience in the biotechnology and blood bank industries.
In 2012, she joined Bayer to manage the Microbiology and Virology groups, currently manages Quality Control Microbiology/Environmental Monitoring/Cell Biology/Virology departments and oversees the operations, method validation, microbial identification, and discrepancy groups.
Anita will be speaking on ‘Investing Sterility Failures’ on day one.

LUCIA CLONTZ, Quality Director, Xellia Pharmaceuticals
Dr. Clontz has more than 30 years of industry experience in quality, pharmaceutical microbiology, laboratory management, operational excellence initiatives, and training. Dr. Clontz is a published author, speaker, and workshop leader at both national and international conferences, and in 2004, she received the PDA’s Distinguished Editor/Author award.
Lucia will be presenting an opening address on day one on ‘Strategic approaches to contamination control’.

HEIDI ANDERSON, Principal Scientist, Microbiology, Abbott
After graduating from the University of Wisconsin with a degree in Medical Microbiology and Immunology she began her career with Abbott’s Diagnostics Division and has continued to work there for nearly 15 years.
Heidi will be speaking on ‘The Conundrum of Microbial Identification’ on day one.

FARNAZ NOWROOZI, Scientist and Manager, Genentech, Inc Farnaz Nowroozi
Farnaz is an SME for Low Endotoxin Recovery topics and a key member of Endotoxin Expert Group at Roche-Genentech.
Farnaz will be speaking on spotlight session on 'New Endotoxin Testing Methods – A mass Spectrometry Based Approach'

For the full agenda and speaker line-up visit the website to download the brochure here – http://www.pharma-microbiology-usa.com/PR1

The event is CPD accredited.

Part of the conference there will also be two interactive half day pre-conference workshops taking place on June 4th, 2019

WORKSHOP A – 08:30AM – 12:30PM
Assessing a Holistic Approach to Microbial Contamination Control
Led by: Ziva Abraham, CEO, Microrite

WORKSHOP B – 1.30PM – 5.30PM
Reviewing the Road Map to a Holistic Approach to Microbial Impurities, Endotoxins and LER
Led by: Friedrich von Wintzingerode, Senior Manager gASAT Microbiology, Global QC, Genentech & Farnaz Nowroozi, Scientist and Manager, Genentech

If you would like to attend as a delegate at this event take full advantage and save US$400 for the 2-day conference (standard price is at US$1999). Register at http://www.pharma-microbiology-usa.com/PR1

________________________________________
Sponsored by: Associates of Cape Cod, bioMérieux, Bioscience International, Charles River, DuPont, FujiFilm & Microbiologics

Interested in sponsoring, exhibiting or speaking at this event?
Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk
________________________________________

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk
Pharmaceutical Microbiology West Coast
June, 5 – 6 June 2019
Hyatt Regency Mission Bay Hotel, CA, USA
http://www.pharma-microbiology-usa.com/PR1
#SMiPharmaMicroUSA

—- END —-
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
+44 20 7827 6000
email us here


Source: EIN Presswire